Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$602,078
+$343,873 QoQ
Shares Held
12,559
+78.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#652
of 1,348 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $45,176,274 across 12 Drug Manufacturers - General names. NVO ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
66,702 | $16,784,891 | |
| 2 | JNJ |
Johnson & Johnson
|
36,605 | $9,296,571 | |
| 3 | LLY |
ELI LILLY & Co
|
7,302 | $8,758,238 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,249 | $4,657,996 | |
| 5 | AMGN |
Amgen Inc
|
6,203 | $2,246,230 | |
| 6 | AZN |
Astrazeneca PLC
|
3,462 | $656,464 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
12,559 | $602,078 | |
| 8 | PFE |
Pfizer Inc
|
24,805 | $597,304 |
All Filings in NVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $602,078 | 12,559 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $258,205 | 7,026 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $314,845 | 6,188 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $296,150 | 5,337 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $336,127 | 4,870 | Shares | Sole | 2025-11-14 | |
| 2024-06-30 | $319,880 | 2,241 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $264,118 | 2,057 | Shares | Sole | 2025-04-22 | |
| 2023-09-30 | $252,904 | 2,781 | Shares | Sole | 2023-10-24 | |
| No filing history on record for this holder in this stock. | ||||||